Negative regulators in RANKL-induced osteoclastogenesis

키워드

참고문헌 (42)

1. ANDERSON, D. M, "A homologue of the TNF receptor and itsligand enhance T-cel growth and dendritic-cell function", 390, pp.175~9 (1997)
2. ASAGIRI, M, "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis", 202, pp.1261~9 (2005)
3. BENEZRA, "a negativeregulator of helix-lop-helix DNA binding proteins", pp.49~59 (1990)
4. 4 Junwon Lee, "The Maf transcription factors: regulators of differentiation", 22, pp.437~41 (1997)
5. BOYLE, W. J, "Osteoclast diferentiation and activation", 423, pp.37~42 (2003)
6. CORDES, S. P, "The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor", pp.1025~34 (1994)
7. EICHMANN, A, "The expressionpattern of the mafB", kr gene in birds and mice reveals that thekreisler phenotype does not represent a nul mutant, 1997, pp.65, 1~22
8. HIROTANI, H, "The calcineurin", nuclear factor of activatedT cels signaling pathway regulates osteoclastogenesis in RAW264.7 cels, 2004, pp.279, 13984~13992
9. HODGKINSON, C. A, "Mutations at the mousemicrophthalmia locus are associated with defects in a geneencoding a novel basic-helix-loop-helix-zipper protein", pp.395~404 (1993)
10. IOTSOVA, V, "Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2", 3, pp.1285~1289 (1997)
11. ISHIKAWA, S, "Involvement of FcRgamma in signal transduction of osteoclast-associated receptor(OSCAR).", 16, pp.1019~1025 (2004)
12. KELLY, L. M., "MafB is an inducer of monocytic diferentiation", 19, pp.1987~1997 (2000)
13. KIM, K, "MafB negatively regulatesRANKL-mediated osteoclast diferentiation" (2007)
14. KIM, K, "Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expresion during tumor necrosisfactor-related activation-induced cytokine-mediated osteoclastogenesis", 280, pp.35209~35216 (2005)
15. KIM, N, "A novel member of the leukocyte receptor complex regulates osteoclast diferentiation", 195, pp.201~209 (2002)
16. KIM, Y, "Contribution of nuclear factor ofactivated T cells c1 to the transcriptional control ofimmunoreceptor osteoclast-associated receptor but nottriggering receptor expressed by myeloid cells-2 during osteoclastogenesis", 280, pp.32905~32913 (2005)
17. KOGA, T, "Costimulatory signals mediated by theITAM motif cooperate with RANKL for bone homeostasis", 428, pp.758~763 (2004)
18. LACEY, D. L, "Osteoprotegerin ligand is a cytokine that regulates osteoclast diferentiation and activation.", 93, pp.165~176 (1998)
19. LASORELLA, A, "Id proteins atthe cross-road of development and cancer", 20, pp.8326~8333 (2001)
20. LEE, J, "Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast diferentiation", 107, pp.2686~2693 (2006)
21. LEE, Z. H, "Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts", 305, pp.21~24 (2003)
22. LUCHIN, A, "The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal diferentiation of osteoclasts", 15, pp.451~460 (2000)
23. LUCHIN, A, "Genetic and physical interactions between Microphthalmia transcription factor and PU 1 are necessary for osteoclast gene expression and diferentiation", 276, pp.36703~36710 (2001)
24. MANSKY, K. C, "Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling", 277, pp.11077~11083 (2002)
25. MASARI, M. E, "Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms", 20, pp.429~440 (2000)
26. MERCK, E, "OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cels and is involved inantigen presentation and activation of human dendritic cells", 104, pp.1386~1395 (2004)
27. MOCSAI, A, "The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate developmentof functional osteoclasts through the Syk tyrosine kinase.", 101, pp.6158~6163 (2004)
28. MOTOHASHI, H, "The world according to Maf", 25, pp.2953~2959 (1997)
29. MOTYCKOVA, G, "Negative regulators in RANKL-induced osteoclastogenesis 5 Linking osteopetrosis and pycnodysostosis: regulation of cathepsin expression by the microphthalmia transcriptionn factor family", 98, pp.5798~57803 (2001)
30. SIEWEKE, M. H, "MafB is an interaction partner and repressor ofEts-1 that inhibits erythroid diferentiation", 85, pp.49~60 (1996)
31. SIMON, M. C, "PU.1 and hematopoiesis: lesons learned from gene targeting experiments", 10, pp.1~8 (1998)
32. SINGH, H, "PU.1, a shared transcriptional regulator of lymphoid and myeloidcell fates", 64, pp.13~20 (1999)
33. SO, H, "Microphthalmia transcription factor and PU.1 synergisticaly induce theleukocyte receptor osteoclast-assexpression.ociated receptor gene", 278, pp.24209~24216 (2003)
34. SUDA, T, "Modulation of osteoclast diferentiation and function by the new members of the tumor necrosis factor receptor and ligand families", 20, pp.345~357 (1999)
35. TAKAYANAGI, H, "Mechanistic insight into osteoclastdiferentiation in osteoimmunology", 83, pp.170~179 (2005)
36. TAKAYANAGI, H, "Induction andactivation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal diferentiation of osteoclasts", 3, pp.889~901 (2002)
37. TEITELBAUM, S. L, "Bone resorption by osteoclasts", 289, pp.1504~1508 (2000)
38. TEITELBAUM, S. L, "Genetic regulation of osteoclast development and function", 4, pp.638~649 (2003)
39. WAGNER, E. F., "Fos", AP-1 proteins in bone and the immune system, 2005, pp.208, 126~140
40. WANG, Z. Q., OVITT, C., GRIGORIADIS, A. E., MOHLE-STEINLEIN, U., RUTHER, U. and WAGNER, E. F, "Bone and haematopoietic defects in mice lacking c-fos", ki ya(saki), pp.741 25190 3597~5 4 602
41. WONG, B. R, "TRANCE is a novel ligand of the tumornecrosis factor receptor family that activates c-Jun Nterminal kinase in T cells", 272, pp.25190~25194 (1997)
42. YASUDA, H, "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis inhibitory factor and is identical to TRANCE, pp.1998, 95[DOI]

관련 논문AI추천